US FDA News: FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing

FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing
Read more: FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing